Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy

American Journal of Hematology

Volumn 68, Issue 3, 2001, Pages 184-188

  Robbins, Daniel ^a   Kulkarni, Roshni ^a   Gera, Renuka ^a   Scott Emuakpor, Ajovi B ^a   Bosma, Kathy ^a   Penner, John A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Desmopressin; Factor VIIa; Factor VIII; Hemophilia; Immune suppression; Inhibitor

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HEMOPHILIA A; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME;

ADOLESCENT; AUTOANTIBODIES; DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; HEMOPHILIA A; HEMOSTATICS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TREATMENT OUTCOME;

EID: 0034770548     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.1176     Document Type: Article

References (40)

1. Factor VIII inhibitors in mild and moderate-severity haemophilia A
2. Factor VIII inhibitors in mild and moderate-severity haemophilia A
3. 593 to Cys mutation
4. Inhibitor of factor VIII in mild hemophilia
5. Factor VIII inhibitor in mild haemophilia
6. Inhibitors to factor VIII in a family with mild haemophilia: Molecular characterization and response to factor VIII and desmopressin
7. Inhibitor to factor VIII in mild haemophilia
8. Successful treatment with prothrombin complex concentrate of postoperative bleeding in a haemophiliac with a factor VIII inhibitor
9. Factor VIII inhibitor developed in a 60-year-old patient with mild haemophilia A after surgery for colon cancer
10. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A
11. Inhibitor to factor VIII in mild haemophilia
12. Mild hemophilia in children: Prevalence, complications, and treatment
13. Prophylaxis in children with haemophilia: Is it the optimal treatment?
14. Recommendations for the treatment of factor VIII inhibitors: From the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party
15. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII
16. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor
17. Exchange transfusion and pulse steroid therapy in a haemophiliac with inhibitor
18. The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin
19. Thrombogenicity associated with factor IX complex concentrates
20. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in hemophiliacs with inhibitors
21. American experience with home use of NovoSeven: Recombinant factor VIIa in hemophiliacs with inhibitors
22. Myocardial infarction in a patient with hemophilia treated with DDAVP
23. Fatal complication of desmopressin
24. Acquired circulating anticoagulants in hemophilia A
25. A factor VIII inhibitor in a mild hemophiliac
26. Factor VIII inhibitor in a patient with mild haemophilia A
27. Acquired inhibitors to coagulation factors
28. Factor VIII antibody in a patient with mild haemophilia
29. Circulating anticoagulants to factor VIII
30. Evaluation of the safety and efficacy of Stimate® (desmopressin acetate, 1.5 mg/ml) nasal spray in a phase-4 multicenter trial
31. Intranasal desmopressin associated hyponatremia: A case report ad literature review
32. Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: A case report and review of 40 patients
33. High responding factor VIII inhibitors in mild haemophilia-is there a link with recent changes in clinical practice?
34. The missense mutation Arg593 Cys is related to antibody formation in a patient with mild hemophilia A
35. Recombinant factor VIIa is a pan-hemostatic agent?
36. Thrombogenicity of prothrombin complex concentrates
37. Vermylen Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor
38. Safety, efficacy and lessons from continuous infusion with rVFVIIa